Weibo Q4 revenue beat estimates at $456.8M, while adjusted EPS missed at $0.40 vs. $0.48 expected. Weibo declared a $0.82 dividend per ADS despite flat revenue and a 6.7% Y/Y drop in profits. Find out which stock just claimed the top spot in the new Benzinga Rankings.

TQQQ is trading lower by 6.6% Thursday afternoon. The new Benzinga Rankings show you exactly how stocks stack up-scoring them across five key factors that matter most to investors. Every day, one stock rises to the top. Which one is leading today?

Dentsply Sirona Q4 EPS missed estimates at $0.26 vs. $0.43 expected, with sales down 10.6% YoY. ZimVie Q4 EPS beat at $0.27 vs. $0.26 expected, but sales missed at $111.52M vs. $113.4M forecasted. The new Benzinga Rankings show you exactly how stocks stack up-scoring them across five key factors ...

Participants on New Capsules showed a lower increase in dementia severity than those on Old Capsules. Chardan upgraded CervoMed to Buy, citing compelling 16-week extension data. Find out which stock just plummeted to the bottom of the new Benzinga Rankings.

Washington, DC, March 13, 2025 ( GLOBE NEWSWIRE ) -- ThinkCareBelieve has published an article covering Week 8 of the America's Transition into The Golden Age under President Trump's leadership.

LIMASSOL, Cyprus, March 13, 2025 ( GLOBE NEWSWIRE ) -- Avenix Fzco has launched Avexbot, an AI-enhanced trading system that introduces a precision-focused approach to GBP/USD trading by combining institutional-grade analytics with real-time market adaptability.

In continuation of Tryg's notice of the annual general meeting on 26 March 2025 at 15:00 CET, TryghedsGruppen smba has announced the nomination of the following four candidates for election to Tryg's Supervisory Board at the annual general meeting:

Renault announces that the 2024 Universal Registration Document ( in French version ) has been filed, in ESEF format, with the French Financial Markets Authority ( Autorité des Marchés Financiers - AMF ) , on March 13, 2025. • the Annual Financial Report for the 2024 financial year which notably ...

Perspective Therapeutics' [212Pb]VMT-α-NET trial showed anti-tumor activity, with one confirmed and two unconfirmed responses. H.C. Wainwright & Co. cites promising preclinical and clinical-stage assets. Find out which stock just plummeted to the bottom of the new Benzinga Rankings.

Orlando's premier luxury destination will celebrate the spring with specially curated events and programing for guests and locals